Abstract
Glutathione S-transferases (GSTs) are involved in the detoxification of xenobiotics, such as several cytostatic drugs, through conjugation with glutathione (GSH). Pi class GST (GST P) liver expression is associated with preneoplastic and neoplastic development and contributes with the drug-resistance phenotype. Ethacrynic acid (EA) is an inhibitor of rat and human GSTs. In addition, causes lipid peroxidation in isolated rat hepatocytes. Therefore, we decided to evaluate the role of the GST/GSH system in isolated hepatocytes from preneoplastic rat livers (IP) in the presence of EA and determine the cytotoxicity of the drug. Our results showed a resistance to the toxic effects of EA since viability and cellular integrity values were significantly higher than control. Initial levels of thiobarbituric acid reactive substances (TBARS) in IP hepatocytes were significantly higher than control and the presence of EA did not change TBARS levels. A diminution in intracellular total GSH was observed by treating with EA isolated hepatocytes from both groups. However, the initial total GSH levels were higher in IP hepatocytes than in control. Immunoblotting analysis showed the presence of GST P in IP animals only. Although alpha and mu class isoenzymes levels were decreased in IP hepatocytes, total GST activity was 1.5-fold higher than in control. In addition, multidrug-resistance protein 2 (Mrp2) showed fivefold decreased levels in IP hepatocytes. In conclusion, increased total GSH, decreased Mrp2 levels and the presence of GST P could be critical factors involved in the resistance of IP hepatocytes to the toxicity of EA.
Similar content being viewed by others
References
Altmann HW (1994) Hepatic neoformations. Pathol Res Pract 190(6):513–577
Armstrong DK, Gordon GB, Hilton J, Streeper RT, Colvin OM, Davidson NE (1992) Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance. Cancer Res 52(6):1416–1421
Batist G, Tulpule A, Sinha BK, Katki AG, Myers CE, Cowan KH (1986) Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261(33):15544–15549
Black SM, Wolf CR (1991) The role of glutathione-dependent enzymes in drug resistance. Pharmacol Ther 51(1):139–154
Bosch FX, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19(3):271–285
Coles B, Ketterer B (1990) The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 25(1):47–70
de Lujan AM, Cerliani JP, Monti J, Carnovale C, Ronco MT, Pisani G, Lugano MC, Carrillo MC (2002) The in vivo apoptotic effect of interferon alfa-2b on rat preneoplastic liver involves Bax protein. Hepatology 35(4):824–833
de Lujan AM, Ronco MT, Ochoa JE, Monti JA, Carnovale CE, Pisani GB, Lugano MC, Carrillo MC (2004) Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1). Hepatology 40(2):394–402
Evers R, Kool M, van DL, Janssen H, Calafat J, Oomen LC, Paulusma CC, Oude Elferink RP, Baas F, Schinkel AH, Borst P (1998) Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest 101(7):1310–1319
Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249(22):7130–7139
Hayes JD, McLellan LI (1999) Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 31(4):273–300
Iersel ML, Ploemen JP, Struik I, van AC, Keyzer AE, Schefferlie JG, van Bladeren PJ (1996) Inhibition of glutathione S-transferase activity in human melanoma cells by alpha,beta-unsaturated carbonyl derivatives Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal. Chem Biol Interact 102(2):117–132
Ji B, Ito K, Sekine S, Tajima A, Horie T (2004) Ethacrynic-acid-induced glutathione depletion and oxidative stress in normal and Mrp2-deficient rat liver. Free Radic Biol Med 37(11):1718–1729
Keen JH, Jakoby WB (1978) Glutathione transferases. Catalysis of nucleophilic reactions of glutathione. J Biol Chem 253(16):5654–5657
Kuzmich S, Vanderveer LA, Walsh ES, LaCreta FP, Tew KD (1992) Increased levels of glutathione S-transferase pi transcript as a mechanism of resistance to ethacrynic acid. Biochem J 281(Pt1):219–224
Llovet JM, Beaugrand M (2003) Hepatocellular carcinoma: present status and future prospects. J Hepatol 38(Suppl1):S136–S149
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
Mannervik B, Alin P, Guthenberg C, Jensson H, Tahir MK, Warholm M, Jornvall H (1985) Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 82(21):7202–7206
Mannervik B, Danielson UH (1988) Glutathione transferases—structure and catalytic activity. CRC Crit Rev Biochem 23(3):283–337
Meyer DJ, Beale D, Tan KH, Coles B, Ketterer B (1985) Glutathione transferases in primary rat hepatomas: the isolation of a form with GSH peroxidase activity. FEBS Lett 184(1):139–143
Morrow CS, Cowan KH (1990) Glutathione S-transferases and drug resistance. Cancer Cells 2(1):15–22
Morrow CS, Smitherman PK, Townsend AJ (1998) Combined expression of multidrug resistance protein (MRP) and glutathione S-transferase P1-1 (GSTP1-1) in MCF7 cells and high level resistance to the cytotoxicities of ethacrynic acid but not oxazaphosphorines or cisplatin. Biochem Pharmacol 56(8):1013–1021
Nies AT, Konig J, Pfannschmidt M, Klar E, Hofmann WJ, Keppler D (2001) Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer 94(4):492–499
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351–358
Pitot HC, Campbell HA, Maronpot R, Bawa N, Rizvi TA, Xu YH, Sargent L, Dragan Y, Pyron M (1989) Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Toxicol Pathol 17(4Pt1):594–611
Ploemen JH, Van OB, van Bladeren PJ (1990) Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate. Biochem Pharmacol 40(7):1631–1635
Sato K (1989) Glutathione transferases as markers of preneoplasia and neoplasia. Adv Cancer Res 52:205–255
Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K (1985) Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 82(12):3964–3968
Seglen PO (1973) Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res 82(2):391–398
Tahir MK, Guthenberg C, Mannervik B (1989) Glutathione transferases in rat hepatoma cells. Effects of ascites cells on the isoenzyme pattern in liver and induction of glutathione transferases in the tumour cells. Biochem J 257(1):215–220
Tietz PS, Holman RT, Miller LJ, LaRusso NF (1995) Isolation and characterization of rat cholangiocyte vesicles enriched in apical or basolateral plasma membrane domains. Biochemistry 34(47):15436–15443
Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27(3):502–522
Tirona RG, Tan E, Meier G, Pang KS (1999) Uptake and glutathione conjugation of ethacrynic acid and efflux of the glutathione adduct by periportal and perivenous rat hepatocytes. J Pharmacol Exp Ther 291(3):1210–1219
Tolman KG, Gray PD, el MS, Luther RR, Janicki RS (1989) Toxicity of uricosuric diuretics in rat hepatocyte culture. Biochem Pharmacol 38(7):1181–1184
Waxman DJ (1990) Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy—a review. Cancer Res 50(20):6449–6454
Williams GM (1989) The significance of chemically-induced hepatocellular altered foci in rat liver and application to carcinogen detection. Toxicol Pathol 17(4Pt1):663–672
Yamamoto K, Masubuchi Y, Narimatsu S, Kobayashi S, Horie T (2002) Toxicity of ethacrynic acid in isolated rat hepatocytes. Toxicol In Vitro 16(2):151–158
Acknowledgments
Supported by research grants from Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT) and from Consejo Nacional de Investigaciones Científicas y Técnicas. JPP is a recipient of a research fellowship from ANPCyT. We thank Dr. Aldo Mottino for the generous gift of the anti-Mrp2 antibody used in this study and Dr. Juan Monti and Elena Ochoa for their helpful technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parody, J.P., Alvarez, M.d.L., Quiroga, A. et al. Hepatocytes isolated from preneoplastic rat livers are resistant to ethacrynic acid cytotoxicity. Arch Toxicol 81, 565–573 (2007). https://doi.org/10.1007/s00204-007-0183-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-007-0183-8